IL2 and prostate cancer: Therefore, our study was clearly in support of the protumor activities of TRIM66 in prostate cancer cells, and corresponding mechanistic investigation highlighted the importance of the TRIM66–STAT2–IL‐2 axis underlying this malignant phenotype.